Postoperative impairment of motor function at train-of-four ratio ≥ 0.9 cannot be improved by sugammadex (1 mg kg-1)

British Journal of Anaesthesia

Volumn 114, Issue 5, 2015, Pages 785-793

  Baumuller E ^a   Schaller, S J ^a   Chiquito Lama, Y ^a   Frick, C G ^a   Bauhofer, T ^a   Eikermann, M ^b   Fink, H ^a   Blobner, M ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

neuromuscular blocking agent; postoperative residual paralysis; quantitative neuromuscularmonitoring; sugammadex

Indexed keywords

PLACEBO; ROCURONIUM; SUGAMMADEX; ANDROSTANE DERIVATIVE; GAMMA CYCLODEXTRIN DERIVATIVE; NEUROMUSCULAR BLOCKING AGENT;

ADULT; ARTICLE; ASSESSMENT OF HUMANS; CONTROLLED STUDY; DRUG ANTAGONISM; FEMALE; GRIP STRENGTH; HUMAN; MAJOR CLINICAL STUDY; MALE; MOTOR DYSFUNCTION; MOTOR PERFORMANCE; MUSCLE FUNCTION; MUSCLE STRENGTH; MUSCULOSKELETAL SYSTEM PARAMETERS; NAUSEA; NERVOUS SYSTEM PARAMETERS; NEUROMUSCULAR MONITORING; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; QUALITY OF RECOVERY SCORE 40; RANDOMIZED CONTROLLED TRIAL; RECOVERY ROOM; SHIVERING; TRAIN OF FOUR RATIO; WELLBEING; ANALYSIS OF VARIANCE; ANESTHETIC RECOVERY; ANTAGONISTS AND INHIBITORS; DOUBLE BLIND PROCEDURE; DRUG EFFECTS; PROCEDURES;

ADULT; ANALYSIS OF VARIANCE; ANDROSTANOLS; ANESTHESIA RECOVERY PERIOD; DOUBLE-BLIND METHOD; FEMALE; GAMMA-CYCLODEXTRINS; HUMANS; MALE; MOTOR SKILLS; MUSCLE STRENGTH; NEUROMUSCULAR MONITORING; NEUROMUSCULAR NONDEPOLARIZING AGENTS;

EID: 84928886759     PISSN: 00070912     EISSN: 14716771     Source Type: Journal    
DOI: 10.1093/bja/aeu453     Document Type: Article

References (44)

1. Viby-Mogensen J, Jørgensen BC, Ording H. Residual Curarization in the Recovery Room. Anesthesiology 1979; 50: 539-41
2. Ali HH, Utting JE, Gray TC. Quantitative assessment of residual antidepolarizing block. I. Br J Anaesth 1971; 43: 473-7
3. Ali HH, Utting JE, Gray TC. Quantitative assessment of residual antidepolarizing block. II. Br J Anaesth 1971; 43: 478-85
4. Murphy GS, Szokol JW, Marymont JH, et al. Intraoperative acceleromyographic monitoring reduces the risk of residual neuromuscular blockade and adverse respiratory events in the postanesthesia care unit. Anesthesiology 2008; 109: 389-98
5. ErikssonLI, SundmanE, OlssonR, et al. Functionalassess-mentof the pharynxat restand duringswallowing inpartiallyparalyzedhumans: simultaneous videomanometry and mechanomyography of awake human volunteers. Anesthesiology 1997; 87: 1035-43
6. Sundman E, Witt H, Olsson R, EkbergO, Kuylenstierna R, Eriksson LI. The incidence and mechanisms of pharyngeal and upper esophageal dysfunction in partially paralyzed humans. Pharyngeal videoradiography and simultaneous manometry after atracurium. Anesthesiology 2000; 92: 977-84
7. Herbstreit F, Peters J, Eikermann M. Impaired upper airway integrity by residual neuromuscular blockade: increased airway collapsibility and blunted genioglossus muscle activity in response to negative pharyngeal pressure. Anesthesiology 2009; 110: 1253-60
8. MurphyGS, BrullSJ.Residualneuromuscularblock: lessonsunlearned. Part I: definitions, incidence, and adverse physiologic effects of residual neuromuscular block. Anesth Analg 2010; 111: 120-8
9. Kopman AF, Yee PS, Neuman GG. Relationship of the train-of-four fade ratio to clinical signs and symptoms of residual paralysis in awake volunteers. Anesthesiology 1997; 86: 765-71
10. Paton WD, Waud DR. The margin of safety of neuromuscular transmission. J Physiol 1967; 191: 59-90
11. Waud BE, Waud DR. The relation between the response to ?trainof- four? stimulation and receptor occlusion during competitive neuromuscular block. Anesthesiology 1972; 37: 413-6
12. Bellace JV, Healy D, Besser MP, Byron T, Hohman L. Validity of the Dexter Evaluation System's Jamar dynamometer attachment for assessment of hand grip strength in a normal population. J Hand Ther 2000; 13: 46-51
13. Peters MJH, van Nes SI, Vanhoutte EK, et al. Revised normative values for grip strength with the Jamar dynamometer. J Peripher Nerv Syst 2011; 16: 47-50
14. Tiffin J, Asher EJ. The Purdue pegboard; norms and studies of reliability and validity. J Appl Psychol 1948; 32: 234-47
15. Myles PS, Weitkamp B, Jones K, Melick J, Hensen S. Validity and reliability of a postoperative quality of recovery score: the QoR-40. Br J Anaesth 2000; 84: 11-5
16. Gornall BF, Myles PS, Smith CL, et al. Measurement of quality of recovery using the QoR-40: a quantitative systematic review. Br J Anaesth 2013; 111: 161-9
17. UnterbuchnerC, BlobnerM, Pühringer F, et al.Developmentofaclinical score todetect postoperative residual curarization. Br J Anaesth 2009; 103: 908-17
18. Murphy GS, Szokol JW, Avram MJ, et al. Postoperative residual neuromuscular blockade is associated with impaired clinical recovery. Anesth Analg 2013; 117: 133-41
19. Donati F, Meistelman C, Plaud B. Vecuronium neuromuscular blockade at the adductor muscles of the larynx and adductor pollicis. Anesthesiology 1991; 74: 833-7
20. Isono S, Ide T, Kochi T, Mizuguchi T, Nishino T. Effects of partial paralysis on the swallowing reflex in conscious humans. Anesthesiology 1991; 75: 980-4
21. Cantineau JP, Porte F, d'Honneur G, Duvaldestin P. Neuromuscular effects of rocuronium on the diaphragm and adductor pollicis muscles in anesthetized patients. Anesthesiology 1994; 81: 585-90
22. Donati F, Meistelman C, Plaud B. Vecuronium neuromuscular blockade at the diaphragm, the orbicularis oculi, and adductor pollicis muscles. Anesthesiology 1990; 73: 870-5
23. Alkhazrajy W, Khorasanee AD, Russell WJ. Muscle weakness after muscle relaxants: an audit of clinical practice. Anaesth Intensive Care 2004; 32: 256-9
24. Amirjani N, Ashworth NL, Olson JL, Morhart M, ChanKM.Validityand reliability of the Purdue Pegboard Test in carpal tunnel syndrome. Muscle Nerve 2011; 43: 171-7
25. Cedborg AI, Sundman E, Boden K, et al. Pharyngeal function and breathing pattern during partial neuromuscular block in the elderly: effects on airway protection. Anesthesiology 2014; 120: 312-25
26. Herbstreit F, Zigrahn D, Ochterbeck C, Peters J, Eikermann M. Neostigmine/glycopyrrolate administered after recovery from neuromuscular block increases upper airway collapsibility by decreasing genioglossus muscle activity in response to negative pharyngeal pressure. Anesthesiology 2010; 113: 1280-8
27. Baldwin CE, Paratz JD, Bersten AD. Muscle strength assessment in critically ill patients with handheld dynamometry: an investigation of reliability, minimal detectable change, and time to peak force generation. J Crit Care 2013; 28: 77-86
28. Hamilton GF, McDonald C, Chenier TC.Measurement of grip strength: validity and reliability of the sphygmomanometer and Jamar grip dynamometer. J Orthop Sports Phys Ther 1992; 16: 215-9
29. Eriksson M, Lindberg C. Hand function in 45 patients with sporadic inclusion body myositis. Occup Ther Int 2012; 19: 108-16
30. Buddenberg LA, Davis C. Test-retest reliability of the Purdue Pegboard Test. Am J Occup Ther 2000; 54: 555-8
31. Leslie K, TroedelS, IrwinK, et al.Qualityof recoveryfromanesthesiain neurosurgical patients. Anesthesiology 2003; 99: 1158-65
32. Myles PS, Hunt JO, Fletcher H, Solly R, Woodward D, Kelly S. Relation between quality of recovery in hospital and quality of life at 3months after cardiac surgery. Anesthesiology 2001; 95: 862-7
33. Fuchs-Buder T, Schreiber JU, Meistelman C. Monitoring neuromuscular block: an update. Anaesthesia 2009; 64(Suppl 1): 82-9
34. Suy K, Morias K, Cammu G, et al. Effective reversal of moderate rocuronium-orvecuronium-inducedneuromuscularblockwithsugammadex, a selective relaxant binding agent. Anesthesiology 2007; 106: 283-8
35. Plaud B, Meretoja O, Hofmockel R, et al. Reversal of rocuroniuminduced neuromuscular blockade with sugammadex in pediatric and adult surgical patients. Anesthesiology 2009; 110: 284-94
36. Sorgenfrei IF, Norrild K, Larsen PB, et al. Reversal of rocuroniuminduced neuromuscular block by the selective relaxant binding agent sugammadex: a dose-finding and safety study. Anesthesiology 2006; 104: 667-74
37. Duvaldestin P, Kuizenga K, Saldien V, et al. A randomized, dose-response study of sugammadex given for the reversal of deep rocuronium- or vecuronium-induced neuromuscular blockade under sevoflurane anesthesia. Anesth Analg 2010; 110: 74-82
38. Groudine SB, Soto R, Lien C, Drover D, Roberts K. A randomized, dose-finding, phase II study of the selective relaxant binding drug, sugammadex, capable of safely reversing profound rocuronium- induced neuromuscular block. Anesth Analg 2007; 104: 555-62
39. Jones RK, Caldwell JE, Brull SJ, Soto RG. Reversal of profoundrocuronium- inducedblockadewithsugammadex:arandomized comparison with neostigmine. Anesthesiology 2008; 109: 816-24
40. de Boer HD, Driessen JJ, Marcus MA, Kerkkamp H, Heeringa M, Klimek M. Reversal of rocuronium-induced (1.2 mg/kg) profound neuromuscular block bysugammadex: a multicenter, dose-finding and safety study. Anesthesiology 2007; 107: 239-44
41. Schaller SJ, Fink H, Ulm K, Blobner M. Sugammadex and neostigmine dose-finding study for reversal of shallow residual neuromuscular block. Anesthesiology 2010; 113: 1054-60
42. Barthel F, Stojeba N, Lyons G, Biermann C, Diemunsch P.Sugammadex in rocuronium anaphylaxis: dose matters. Br J Anaesth 2012; 109: 646-7
43. Hans GA, Bosenge B, Bonhomme VL, Brichant JF, Venneman IM, Hans PC. Intravenous magnesium re-establishes neuromuscular block after spontaneous recovery from an intubating dose of rocuronium: a randomised controlled trial. Eur J Anaesthesiol 2012; 29: 95-9
44. FawcettWJ, Stone JP. Recurarization in the recovery roomfollowing the use of magnesium sulphate. Br J Anaesth 2003; 91: 435-8